Meeting Coverage:

Retina World Congress Meeting

RWC: 2017

How Long-Term RVO Patients Respond to Therapy

Show Description +

Antonio Casella, MD, PhD, reviews his presentation on the pathophysiology and outcomes of patients with chronic retinal vein occlusion (RVO). Dr. Casella discusses how laser, anti-VEGF injections, and steroids play a role in RVO treatment, and how populations from various clinical trials have responded to therapy.

Posted: 1/25/2017

How Long-Term RVO Patients Respond to Therapy

Antonio Casella, MD, PhD, reviews his presentation on the pathophysiology and outcomes of patients with chronic retinal vein occlusion (RVO). Dr. Casella discusses how laser, anti-VEGF injections, and steroids play a role in RVO treatment, and how populations from various clinical trials have responded to therapy.

Posted: 1/25/2017


Please log in to leave a comment.

More From RWC: 2017 Coverage

Abicipar Pegol in Phase 2

Pravin Dugel, MD

OCTA in DR

Nadia Waheed, MD

Managing TRDs

Maria H. Berrocal, MD